Cargando…
Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis
Metabolic reprogramming has been recognized as an essential emerging cancer hallmark. Dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinase (PDK), has been reported to have anti-cancer effects by reversing tumor-associated glycolysis. This study was performed to explore the anti-cance...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624089/ https://www.ncbi.nlm.nih.gov/pubmed/34830434 http://dx.doi.org/10.3390/ijms222212553 |
_version_ | 1784606088277000192 |
---|---|
author | Al-Azawi, Aya Sulaiman, Shahrazad Arafat, Kholoud Yasin, Javed Nemmar, Abderrahim Attoub, Samir |
author_facet | Al-Azawi, Aya Sulaiman, Shahrazad Arafat, Kholoud Yasin, Javed Nemmar, Abderrahim Attoub, Samir |
author_sort | Al-Azawi, Aya |
collection | PubMed |
description | Metabolic reprogramming has been recognized as an essential emerging cancer hallmark. Dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinase (PDK), has been reported to have anti-cancer effects by reversing tumor-associated glycolysis. This study was performed to explore the anti-cancer potential of DCA in lung cancer alone and in combination with chemo- and targeted therapies using two non-small cell lung cancer (NSCLC) cell lines, namely, A549 and LNM35. DCA markedly caused a concentration- and time-dependent decrease in the viability and colony growth of A549 and LNM35 cells in vitro. DCA also reduced the growth of tumor xenografts in both a chick embryo chorioallantoic membrane and nude mice models in vivo. Furthermore, DCA decreased the angiogenic capacity of human umbilical vein endothelial cells in vitro. On the other hand, DCA did not inhibit the in vitro cellular migration and invasion and the in vivo incidence and growth of axillary lymph nodes metastases in nude mice. Treatment with DCA did not show any toxicity in chick embryos and nude mice. Finally, we demonstrated that DCA significantly enhanced the anti-cancer effect of cisplatin in LNM35. In addition, the combination of DCA with gefitinib or erlotinib leads to additive effects on the inhibition of LNM35 colony growth after seven days of treatment and to synergistic effects on the inhibition of A549 colony growth after 14 days of treatment. Collectively, this study demonstrates that DCA is a safe and promising therapeutic agent for lung cancer. |
format | Online Article Text |
id | pubmed-8624089 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86240892021-11-27 Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis Al-Azawi, Aya Sulaiman, Shahrazad Arafat, Kholoud Yasin, Javed Nemmar, Abderrahim Attoub, Samir Int J Mol Sci Article Metabolic reprogramming has been recognized as an essential emerging cancer hallmark. Dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinase (PDK), has been reported to have anti-cancer effects by reversing tumor-associated glycolysis. This study was performed to explore the anti-cancer potential of DCA in lung cancer alone and in combination with chemo- and targeted therapies using two non-small cell lung cancer (NSCLC) cell lines, namely, A549 and LNM35. DCA markedly caused a concentration- and time-dependent decrease in the viability and colony growth of A549 and LNM35 cells in vitro. DCA also reduced the growth of tumor xenografts in both a chick embryo chorioallantoic membrane and nude mice models in vivo. Furthermore, DCA decreased the angiogenic capacity of human umbilical vein endothelial cells in vitro. On the other hand, DCA did not inhibit the in vitro cellular migration and invasion and the in vivo incidence and growth of axillary lymph nodes metastases in nude mice. Treatment with DCA did not show any toxicity in chick embryos and nude mice. Finally, we demonstrated that DCA significantly enhanced the anti-cancer effect of cisplatin in LNM35. In addition, the combination of DCA with gefitinib or erlotinib leads to additive effects on the inhibition of LNM35 colony growth after seven days of treatment and to synergistic effects on the inhibition of A549 colony growth after 14 days of treatment. Collectively, this study demonstrates that DCA is a safe and promising therapeutic agent for lung cancer. MDPI 2021-11-21 /pmc/articles/PMC8624089/ /pubmed/34830434 http://dx.doi.org/10.3390/ijms222212553 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Al-Azawi, Aya Sulaiman, Shahrazad Arafat, Kholoud Yasin, Javed Nemmar, Abderrahim Attoub, Samir Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis |
title | Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis |
title_full | Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis |
title_fullStr | Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis |
title_full_unstemmed | Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis |
title_short | Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis |
title_sort | impact of sodium dichloroacetate alone and in combination therapies on lung tumor growth and metastasis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624089/ https://www.ncbi.nlm.nih.gov/pubmed/34830434 http://dx.doi.org/10.3390/ijms222212553 |
work_keys_str_mv | AT alazawiaya impactofsodiumdichloroacetatealoneandincombinationtherapiesonlungtumorgrowthandmetastasis AT sulaimanshahrazad impactofsodiumdichloroacetatealoneandincombinationtherapiesonlungtumorgrowthandmetastasis AT arafatkholoud impactofsodiumdichloroacetatealoneandincombinationtherapiesonlungtumorgrowthandmetastasis AT yasinjaved impactofsodiumdichloroacetatealoneandincombinationtherapiesonlungtumorgrowthandmetastasis AT nemmarabderrahim impactofsodiumdichloroacetatealoneandincombinationtherapiesonlungtumorgrowthandmetastasis AT attoubsamir impactofsodiumdichloroacetatealoneandincombinationtherapiesonlungtumorgrowthandmetastasis |